| 0 (0%) | 12-27 00:26 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 5.73 | 1-year : | 6.69 |
| Resists | First : | 4.9 | Second : | 5.73 |
| Pivot price | 4.84 |
|||
| Supports | First : | 4.68 | Second : | 4.55 |
| MAs | MA(5) : | 4.84 | MA(20) : | 4.85 |
| MA(100) : | 4.76  |
MA(250) : | 4.96 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 32.1 |
D(3) : | 34.2 |
| RSI | RSI(14): 56 | |||
| 52-week | High : | 5.96 | Low : | 4.4 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ SBT ] has closed above bottom band by 36.8%. Bollinger Bands are 66.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 7 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 4.85 - 4.88 | 4.88 - 4.89 |
| Low: | 4.77 - 4.81 | 4.81 - 4.83 |
| Close: | 4.79 - 4.84 | 4.84 - 4.88 |
Fri, 26 Dec 2025
(SBT) Trading Signals (SBT:CA) - Stock Traders Daily
Wed, 29 Oct 2025
Sonoma Biotherapeutics reports promising early data from phase 1 rheumatoid arthritis trial - PharmaTimes
Thu, 25 Sep 2025
SBT GRVL® Returns to One-Day Format and Introduces New Courses for 2026 - Outdoor Sportswire
Wed, 30 Jul 2025
SBT GRVL to return in 2026 as 1-day event with 2,750-rider cap - SteamboatToday.com
Tue, 29 Jul 2025
SBT GRVL® is approved for 2026 - Steamboat Radio
Mon, 30 Jun 2025
Wertz and Rollins Claim Victory at 2025 SBT GRVL® Presented by Wahoo - Endurance Sportswire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 52 (M) |
| Shares Float | 28 (M) |
| Held by Insiders | 65 (%) |
| Held by Institutions | 26.8 (%) |
| Shares Short | 323 (K) |
| Shares Short P.Month | 297 (K) |
| EPS | 0.03 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 6.38 |
| Profit Margin | 3.2 % |
| Operating Margin | 11.9 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0.6 % |
| Qtrly Rev. Growth | -9.9 % |
| Gross Profit (p.s.) | 1.26 |
| Sales Per Share | 1.26 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | -80 % |
| Operating Cash Flow | -2 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 121 |
| PEG Ratio | 0 |
| Price to Book value | 0.75 |
| Price to Sales | 3.83 |
| Price to Cash Flow | -119.41 |
| Dividend | 4.84 |
| Forward Dividend | 0 |
| Dividend Yield | 100.2% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|